Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001002192 | SCV000289503 | benign | Aortic aneurysm, familial thoracic 8 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311069 | SCV000319796 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001580043 | SCV000532845 | likely benign | not provided | 2021-08-02 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000660232 | SCV000782235 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002192 | SCV001160064 | benign | Aortic aneurysm, familial thoracic 8 | 2023-09-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001580043 | SCV004125369 | benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | PRKG1: BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479074 | SCV004223190 | benign | not specified | 2023-11-27 | criteria provided, single submitter | clinical testing | Variant summary: PRKG1 c.1071A>G alters a conserved nucleotide resulting in a synonymous change. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00084 in 249390 control chromosomes. The observed variant frequency is approximately 67.043 fold of the estimated maximal expected allele frequency for a pathogenic variant in PRKG1 causing Thoracic Aortic Aneurysms And Dissections phenotype (1.3e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1071A>G in individuals affected with Thoracic Aortic Aneurysms And Dissections and no experimental evidence demonstrating its impact on protein function have been reported. Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV002311069 | SCV004239618 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977674 | SCV004797890 | likely benign | PRKG1-related disorder | 2021-09-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001580043 | SCV001809466 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001580043 | SCV001929373 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001580043 | SCV001966768 | likely benign | not provided | no assertion criteria provided | clinical testing |